Core Points - The announcement details the pledge of shares by the controlling shareholders of Tianyu Biotechnology Co., Ltd, specifically Mr. Luo Weiguo and Mr. Shi Dongwei [1][2] Group 1: Shareholding and Pledge Details - As of the announcement date, Mr. Luo Weiguo holds 37,251,829 shares, accounting for 12.84% of the total share capital, while Mr. Shi Dongwei holds 32,338,800 shares, accounting for 11.15% [1] - After the pledge, Mr. Luo has pledged a total of 22,000,000 shares, which is 59.06% of his holdings and 7.58% of the total share capital; Mr. Shi has pledged 29,000,000 shares, which is 89.68% of his holdings and 9.99% of the total share capital [1] - Together, Mr. Luo and Mr. Shi hold 69,590,629 shares, representing 23.98% of the total share capital, and after the pledge, they have pledged a total of 51,000,000 shares, which is 73.29% of their holdings and 17.58% of the total share capital [1] Group 2: Legal and Financial Status - Due to a legal dispute, 14,375,524 shares held by Mr. Luo are judicially frozen, and 3,181,856 shares held by Mr. Shi are also frozen due to a contractual dispute [2] - Both shareholders have good credit status and possess the financial capability to repay, with repayment funds sourced from their own funds; the risk associated with the pledged shares is controllable, and there is currently no risk of forced liquidation [2][3] Group 3: Impact on the Company - The pledged shares will not affect the company's main business, financing credit, financing costs, or ongoing operational capabilities [3] - The pledge will not influence the shareholders' ability to appoint directors to the company, nor will it affect the relationship between shareholders and the company regarding property, business, assets, or personnel [3]

天域生物科技股份有限公司（以下简称"公司"）于 2025 年 08 月 05 日收到 公司控股股东、实际控制人罗卫国先生及史东伟先生的书面函告，获悉其所持有 的公司部分股份办理了质押登记手续，具体情况如下： 证券代码：603717 证券简称：天域生物 公告编号：2025-055 天域生物科技股份有限公司 关于控股股东所持公司部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、上市公司股份质押 1、本次股份质押的基本情况 | | 是否 | 本次质押 | 是否 | | | | 占其所 | 占公 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 为控 | | | 质押起始 | 质押到期 | | | 司总 | 融资 | | 名称 | 股股 | 股数 | 补充 | 日 | 日 | 质权人 | 持股份 | 股本 | 资金 | | | | （股） | 质押 | | | | 比例 | | | | | 东 | ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次诉讼的背景 证券代码：603717 证券简称：天域生物 公告编号：2025-054 天域生物科技股份有限公司 关于公司提起诉讼的公告 （一）投资情况及业绩承诺、补偿约定 2022 年 03 月 28 日，天域生物科技股份有限公司（以下简称"公司"）与青 海聚之源新材料有限公司（以下简称"聚之源"或"标的公司"）、刘炳生先生 签订《股权战略投资协议》（以下简称"《股权投资协议》"），公司以货币资 金 2.1 亿元增资聚之源获得 35%的股权。聚之源及刘炳生承诺：标的公司在 2022 年度、2023 年度和 2024 年度承诺经审计的累计扣除非经常性损益后归属于母公 司（合并报表，下同）的净利润为人民币 9 亿元，净利润考核按三年总数计算； 1 案件所处的诉讼阶段：已立案受理，尚未开庭审理 上市公司所处的当事人地位：原告 涉案的金额：暂无 是否会对上市公司损益产生负面影响：由于本案尚未开庭审理，对本期 利润或期后利润的影响存在不确定性。本次诉讼旨在通过法律途径 ...

累计担保情况 | 对外担保逾期的累计金额（万元） | / | | --- | --- | | 截至本公告日上市公司及其控股子 | | | 公司对外担保总额（万元） | 112,133.65 | | （实际发生的担保余额，不含本次） | | | 对外担保总额占上市公司最近一期 | 216.17 | | 经审计净资产的比例（%） | | | 特别风险提示（如有请勾选） | 对外担保总额超过最近一期经审计净资 | | 产 | 100% | | | □担保金额超过上市公司最近一期经审计 | | | 净资产 50% | | | □对合并报表外单位担保金额达到或超过 | | | 最近一期经审计净资产 30%的情况下 | | | 对资产负债率超过 70%的单位提供担保 | 一、担保情况概述 证券代码：603717 证券简称：天域生物 公告编号：2025-053 天域生物科技股份有限公司 关于公司 2025 年度对外担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 ...

上海市锦天城律师事务所 关于天域生物科技股份有限公司 2025年第二次临时股东大会的 法律意见书 锦 天 域 律师事务 所 ALLBRIGHT LAW OFFICES 地址:上海市浦东新区银城中路 501 号上海中心 11、12 层 电话: 021-20511000 传真: 021-20511999 邮编: 200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于天域生物科技股份有限公司 2025年第二次临时股东大会的法律意见书 致:天域生物科技股份有限公司 上海市锦天城律师事务所(以下简称"本所")接受天域生物科技股份有限 公司(以下简称"公司")委托,就公司召开 2025年第二次临时股东大会(以 下简称"本次股东大会")的有关事宜,根据《中华人民共和国公司法》(以下 简称"《公司法》")《上市公司股东会规则》等法律、法规和其他规范性文件 以及《天域生物科技股份有限公司章程》(以下简称"《公司章程》")的有关 规定,出具本法律意见书。 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则(试行)》等规定,严格履行 了法定职责, ...

证券代码：603717 证券简称：天域生物 公告编号：2025-052 天域生物科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 7 月 16 日 (二)股东大会召开的地点：上海市杨浦区国权北路 1688 号湾谷科技园 C4 幢二层 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 召开和表决符合《公司法》及《公司章程》的规定。 (五)公司董事、监事和董事会秘书的出席情况 | 1、出席会议的股东和代理人人数 | 168 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 1,770,880 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 0.8043 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，公司董 ...

Group 1 - The company expects a net profit attributable to shareholders of 8 million to 12 million yuan for the first half of 2025, representing an increase of 177.14 thousand to 577.14 thousand yuan compared to the same period last year, with a year-on-year growth of 28.44% to 92.66% [2][3] - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -18 million and -12 million yuan, which is a decrease of 893.04 thousand to 1,493.04 thousand yuan compared to the same period last year [2][3] - The total sales revenue is projected to be 311.53 million yuan, an increase of 17.49% compared to the same period last year, driven by stable improvements in pig farming operations [2][3] Group 2 - The company reported a total profit of 14.74 million yuan and a net profit attributable to shareholders of 6.23 million yuan for the same period last year [2] - The earnings per share for the previous year was 0.0215 yuan [2] - The increase in asset disposal income is attributed to renegotiations regarding rent reductions and pig farm renovations [2]

[Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company anticipates H1 2025 net profit attributable to shareholders to range from RMB 8 million to RMB 12 million, while net profit after non-recurring items is expected to be a loss of RMB 12 million to RMB 18 million, indicating an expanded loss H1 2025 Performance Forecast Summary | Indicator | H1 2025 Forecast | Prior Period | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Parent Company Shareholders | RMB 8 million to RMB 12 million | RMB 6.2286 million | +28.44% to +92.66% | | Net Profit Attributable to Parent Company Shareholders After Non-Recurring Items | RMB -18 million to RMB -12 million | RMB -3.0696 million | Loss increased by RMB 8.9304 million to RMB 14.9304 million | - This performance forecast represents preliminary calculations by the company's finance department and has not been audited by a certified public accountant[6](index=6&type=chunk) [Review of Prior Period Performance](index=2&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5) In H1 2024, the company reported net profit attributable to shareholders of RMB 6.2286 million, with a net loss of RMB 3.0696 million after non-recurring items, and basic EPS of RMB 0.0215 H1 2024 Key Financial Indicators | Indicator | H1 2024 Data | | :--- | :--- | | Total Profit | RMB 14.7447 million | | Net Profit Attributable to Parent Company Shareholders | RMB 6.2286 million | | Net Profit Attributable to Parent Company Shareholders After Non-Recurring Items | RMB -3.0696 million | | Earnings Per Share | RMB 0.0215 | [Analysis of Performance Change Reasons](index=2&type=section&id=%E4%B8%89%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%A2%9E%E7%9A%84%E4%B8%BB%E8%A6%81%E5%8E%9F%E5%9B%A0) The projected increase in net profit attributable to shareholders is primarily due to stable growth in hog sales and a one-time asset disposal gain, while the expanded loss in net profit after non-recurring items is mainly attributed to reduced interest income - Stable improvement in the operating performance of the hog farming business is a primary driver of net profit growth[9](index=9&type=chunk) Hog Sales Business Performance | Hog Sales Business | H1 2025 Data | Year-on-Year Growth | | :--- | :--- | :--- | | Sales Volume | **204,200 heads** | +21.52% | | Sales Revenue | **RMB 311.5323 million** | +17.49% | - Renegotiation of the pig farm lease contract in Caidian District, Wuhan City, resulted in reduced rent and rent exemption during the renovation period, which is expected to increase the company's asset disposal gains[9](index=9&type=chunk) - The increased loss in net profit after non-recurring items is primarily due to a decrease in interest income during the reporting period[9](index=9&type=chunk) [Risk Warning and Other Disclosures](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company emphasizes that this unaudited performance forecast is a preliminary calculation, and investors should refer to the officially disclosed 2025 semi-annual report for final accurate financial data - The company states that this performance forecast is preliminary and unaudited, advising investors to be aware of investment risks and rely on the final semi-annual report for definitive data[10](index=10&type=chunk)[11](index=11&type=chunk)

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets have announced significant developments, including management changes, stock trading fluctuations, and major contracts, which may present investment opportunities and risks for investors [2]. Group 1: Management Changes and Legal Issues - Scanda's chairman and general manager, Li Yuejie, along with director Zhu Chuncheng, have been subjected to criminal coercive measures due to alleged violations related to information disclosure [3]. - Longhong High-Tech is planning to acquire 100% equity of Guangxi Changke, leading to a stock suspension for up to 10 trading days [6]. Group 2: Stock Trading and Performance - New Asia Electronics reported abnormal stock trading with a cumulative price deviation exceeding 20% over three days, while confirming that its operations are normal and consistent with previously disclosed share reduction plans [5]. - ST Tiexin announced the removal of risk warnings and a name change, which will increase the trading limit from 5% to 10% [8]. Group 3: Financial Performance Forecasts - Industrial Fulian expects a net profit increase of 36.84% to 39.12% year-on-year for the first half of 2025, driven by a surge in AI-related business [18]. - Huayou Cobalt anticipates a net profit increase of 55.62% to 67.59% for the same period, benefiting from integrated operations and rising cobalt prices [19]. - Guoli Co. forecasts a staggering net profit increase of 130.91% to 158.08% for the first half of 2025, attributed to new product and market expansions [20]. - Bangji Technology expects a net profit increase of 166.77% to 200.91%, driven by increased sales from direct sales channels [21]. - Lier Chemical predicts a net profit increase of 185.24% to 196% due to rising product sales and cost reduction efforts [25]. Group 4: Major Contracts and Projects - Huadian Science and Technology signed significant contracts worth approximately RMB 25.16 billion for coal handling and transportation systems [41]. - Aerospace Engineering is the first candidate for a project with a bid of RMB 23.92 billion for a coal gasification facility [43].

2025 年 1-6 月，公司累计销售生猪 20.42 万头，同比上升 21.52%；累计销售 收入 31,153.23 万元，同比上升 17.49%。 2025 年 6 月末，公司生猪存栏 14.44 万头，同比上升 2.34%，环比上升 2.14%。 证券代码：603717 证券简称：天域生物 公告编号：2025-050 天域生物科技股份有限公司 2025 年 6 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）现将 2025 年 6 月养殖业务 主要经营数据公告如下： 一、2025 年 6 月养殖行业主要经营数据 2025 年 6 月，公司销售生猪 3.18 万头，销售收入 3,748.42 万元，环比变动分 别为 28.00%、-7.19%，同比变动分别为 61.57%、-4.33%。 1 2、基于生猪市场价格大幅波动以及公司投苗节奏变化等因素影响，未来公 司生猪销售数量和销售收入存在月度波动风险，敬请广大投资者注意投资风险。 特此公告。 天域生物 ...